A case report on MDS – MPD overlap syndrome – a diagnostic dilemma

  • Dr Anita Omhare GSVM Medical College, Kanpur, Former SR St. Stephen’s College, New Delhi
  • Dr Sanjeev Kumar Singh UPRIMS, Etawah
  • Dr Kanchan Srivastava BRD Medical College, Gorakhpur, Former Lecturer, GSVM Medical College, Kanpur
  • Dr Vandana Mishra GSVM Medical College, Kanpur, 5Dr Shilpa U. Vahikar, Pathology, Associate Professor, BRD Medical College, Gorakhpur
  • Dr Shilpa U. Vahikar Pathology, Associate Professor, BRD Medical College, Gorakhpur, UP, India
Keywords: Myelodysplastic, Myeloproliferative, Thrombocytosis, Sideroblasts

Abstract

Refractory anemia with ring sideroblasts and thrombocytosis (RARS - T) is a rare disease with a controversial status which presents a diagnostic dilemma as it shows overlapping clinical, laboratory and morphological features of two distinct entities-myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). In WHO classification RARS–T is included in MDS/MPN–U category. We report a case of 54 years female who presented with weakness, intermittent fever, anemia along with thrombocytosis. Hematological workup revealed hypercellular marrow with abnormal megakaryocytes and presence of ring sideroblasts (46%). Further, presence of JAK2V617F mutation indicated an underlying MPN and presence of ring sideroblasts an element of MDS. RARS-T was first defined in 2001 as an overlap syndrome. Whether RARS-T is a separate clinical entity or a result of additional acquired genetic defect resulting in progression of RARS/ Essential Thrombocytosis (ET) is still a topic for debate. Hence this unusual case emphasizes need for awareness of this entity among clinicians and pathologists to enable its accurate diagnosis and appropriate management.

Downloads

Download data is not yet available.

References

1. Shimizu-Kohno K, Kimura Y, Kiyasu J, Miyoshi H, Yoshida M, Ichikawa R, Niino D, Ohshima K. Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases. Pathol Int. 2012 Sep;62(9):577-82. doi: 10.1111/j.1440-1827.2012.02844.x.

2. Schnittger S, de Sauvage FJ, Le Paslier D, Fonatsch C. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia. 1996 Dec;10(12):1891-6.

3. Thiele J, Kvasnicka HM. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders. Semin Thromb Hemost. 2006 Apr; 32(3) : 219- 230. PMID:16673276.DOI: 10.1055/s-2006-939433.

4. Tefferi A, Lasho TL, Schwager SM, et al. The JAK2 (V617F) tyrosine kinase mutation in myelofibrosid with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 2005; 131: 320 -328.DOI 10.1111/i.1365-2141.2005.05776.x

5. Shaw GR, Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of elder adults, Br J Haematol, 2005 , 131 (2) : 180-184.

6. Steensma DP, Caudill JS, Pardanani A, McClure RF, Lasho TL, Tefferi A. MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count. Haematologica. 2006 Dec;91(12 Suppl):ECR57.

7. Tatic A, Vasilică M, Coliţă A, Vasilache D, Dobrea C, Jardan C, Găman AM, Crişan AM, Coliţă D, Coriu D. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases. Rom J Morphol Embryol. 2013;54(4):1177-82.
A case report on MDS – MPD overlap syndrome – a diagnostic dilemma
CITATION
DOI: 10.17511/jopm.2017.i01.12
Published: 2017-03-31
How to Cite
Dr Anita Omhare, Dr Sanjeev Kumar Singh, Dr Kanchan Srivastava, Dr Vandana Mishra, & U. Vahikar, S. (2017). A case report on MDS – MPD overlap syndrome – a diagnostic dilemma. Tropical Journal of Pathology and Microbiology, 3(1), 67-70. https://doi.org/10.17511/jopm.2017.i01.12
Section
Case Report